45 results on '"RIZZELLO, F."'
Search Results
2. In vivo association to human colon of Lactobacillus paracasei B21060: Map from biopsies
3. Infliximab in the treatment of Crohn's disease: Predictors of response in an Italian multicentric open study
4. Probiotics — Role in inflammatory bowel disease
5. AF.49 DETERMINANTS OF COVID-19 VACCINE HESITANCY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD): RESULTS OF A NATIONAL SURVEY OF THE ITALIAN IBD PATIENTS’ ASSOCIATION (AMICI ONLUS)
6. T04.01.23 SAFETY OF VEDOLIZUMAB IN THE TREATMENT OF IBD IN A SINGLE TERTIARY CENTER
7. T04.01.14 REAL-LIFE LONG-TERM EFFECTIVENESS AND TREATMENT PERSISTENCE OF VEDOLIZUMAB IN A SINGLE TERTIARY CARE COHORT OF CROHN'S DISEASE PATIENTS
8. OC.12.6 PREVALENCE OF ANAEMIA IN INFLAMMATORY BOWEL DISEASE: PRELIMINARY RESULTS OF THE OBSERVATIONAL ITALIAN MULTICENTRE IG-IBD STUDY RIDART 1
9. OC.13.2 PILLCAMTM CROHN'S SYSTEM FOR CAPSULE ENDOSCOPY: RESULTS OF THE FIRST OBSERVATIONAL MULTI-CENTER STUDY
10. PC.01.4 PREVALENCE OF ANAEMIA IN INFLAMMATORY BOWEL DISEASE: PRELIMINARY RESULTS OF THE OBSERVATIONAL ITALIAN MULTICENTRE IG-IBD STUDY RIDART 1
11. P.08.17 SINGLE VS DUAL-CAMERA: A COMPARATIVE ANALYSIS OF COLON CAPSULE ENDOSCOPY TO EVALUATE THE SMALL BOWEL
12. P.08.18 A NEW DEDICATED CAPSULE FOR DIAGNOSIS AND MONITORING OF CROHN'S DISEASE. FIRS PATIENT SERIES
13. OC.16.3 THE INTERPLAY BETWEEN CLINICIANS AND PATHOLOGISTS FOR THE DIAGNOSIS AND MANAGEMENT OF INFLAMMATORY BOWEL DISEASE IN ITALY: AN IG-IBD SURVEY
14. P.11.19: Maintenance of Deep Remission in Patients with Ulcerative Colitis Treated with Thiopurines after Withdrawal of the Drug: Perspective Real-Life Experience of a Single Center
15. P.05.2: Unmet Needs of Physicians Managing Inflammatory Bowel Disease. A Survey of the Italian Group for Inflammatory Bowel Disease (IG-IBD)
16. P.06.23: Capsule Endoscopy – Accuracy and Prognostic Value of Small Bowel Lesions in Patients with Crohn’s Disease
17. P.05.3: Limitations and Difficulties in using Anti-TNF Alpha Agents in Inflammatory Bowel Disease. A Survey of the Italian Group for Inflammatory Bowel Disease (IG-IBD)
18. OC.14.9: Logistic and Scientific Needs for Professional Updating for Physicians Managing Inflammatory Bowel Disease. A Survey of the Italian Group for Inflammatory Bowel Disease (IG-IBD)
19. P.08.2 THE LONG-TERM CLINICAL COURSE OF REFRACTORY CHRONIC POUCHITIS AFTER INFLIXIMAB THERAPY
20. P.01.2 ADALIMUMAB FOR THE TREATMENT OF POST-OPERATIVE RECURRENCE OF CROHN'S DISEASE. A SINGLE CENTRE EXPERIENCE
21. OC.11.3 EARLY POST-OPERATIVE ENDOSCOPIC RECURRENCE IN CROHN'S DISEASE: DATA FROM A LARGE PROSPECTIVE ITALIAN MULTICENTER COHORT (AN IG-IBD STUDY)
22. OC.11.4 RE-GAIN OF RESPONSE IN CROHN'S DISEASE ADALIMUMAB (ADA) DOSE-ESCALATING FAILURE OR EARLY RELAPSE. A SINGLE CENTRE EXPERIENCE
23. P.06.2 EFFICACY, SAFETY, IMPACT ON NATURAL HISTORY OF LONG-TERM TREATMENT WITH THIOPURINES IN CROHN'S DISEASE PATIENTS. A SINGLE CENTER EXPERIENCE
24. P.05.8 ORAL BECLOMETHASONE DIPROPIONATE IN THE TREATMENT OF CHRONIC REFRACTORY POUCHITIS
25. OC.12.3 EARLY POST-OPERATIVE ENDOSCOPIC RECURRENCE IN CROHN'S DISEASE IN A LARGE PROSPECTIVE ITALIAN MULTICENTER COHORT
26. OC.12.1 INTEROBSERVER AGREEMENT IN IBD SCORES REQUIRES EXPERTISE AND EDUCATION: PRELIMINARY RESULTS FROM AN ONGOING IG-IBD STUDY
27. OC.06.3 ADALIMUMAB IN ACTIVE ULCERATIVE COLITIS: A “REAL-LIFE” OBSERVATIONAL STUDY
28. OC.06.2 LONG-TERM OUTCOME AFTER INFLIXIMAB TREATMENT FOR DISTAL REFRACTORY ULCERATIVE COLITIS. A SINGLE TERTIARY CENTER EXPERIENCE
29. CS.02.3 ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE: LONG TERM RESULTS IN A SINGLE TERTIARY CENTER
30. P.1.23: CELL PROLIFERATION ACTIVITY OF OESOPHAGEAL SQUAMOUS EPITHELIUM IN ERD IS REDUCED COMPARED TO NERD
31. 8 Poor responders
32. P.70 ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE: A SINGLE CENTER EXPERIENCE IN 64 PATIENTS
33. P.17 ROLE OF CB1 IN THE EROSIVE AND NON-EROSIVE GASTRO-ESOPHAGEAL REFLUX DISEASE
34. OC.07.1 ADALIMUMAB IS EFFECTIVE IN THE TREATMENT OF ACTIVE LUMINAL CROHN'S DISEASE AND MUCOSAL HEALING: A SINGLE CENTER EXPERIENCE IN 170 PATIENTS
35. Refractory pouchitis: The role of wireless capsule endoscopy
36. 3 P Probiotic therapy as a prophylaxis in ileo-anal anastomosis patients decreases interferon gamma, interleukin 1 beta and interleukin 8 MRNA expression
37. 78 P High dose of probiotics is effective in the treatment of mild pouchitis. A pilot study
38. Oral beclomethasone dipropionate versus oral 5-aminosalicylic acid in the treatment of active ulcerative colitis: A randomised, 4 week, controlled study
39. Chemokine expression in pouchitis
40. Bacteria in pouch tissue
41. Prophylaxis of postoperative recurrence of Crohn's disease: Combination of antibiotic and probiotic versus mesalamine
42. Highly concentrated probiotics prevent pouchitis onset
43. Highly concentrated probiotics prevent pouchitis onset
44. Prophylaxis of postoperative recurrence of Crohn's disease: Combination of antibiotic and probiotic versus mesalazine
45. Chemokine expression in pouchitis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.